Forced Vital Capacity in Patients with Idiopathic Pulmonary Fibrosis: Test Properties and Minimal Clinically Important Difference
Roland M. du Bois(Imperial College London), Athol U. Wells(St Thomas' Hospital), Alex Kartashov(Policy Analysis (United States)), Carlo Albera(University of Turin), Michiel Thomeer(Universitair Ziekenhuis Leuven), Talmadge E. King(University of California, San Francisco), Derek Weycker(Policy Analysis (United States)), Williamson Z. Bradford(InterScience (United States)), Paul W. Noble(Cedars-Sinai Medical Center), Ulrich Costabel(Ruhrlandklinik), Steven A. Sahn(Medical University of South Carolina), Dominique Valeyre(Inserm), Lisa Lancaster(Vanderbilt University Medical Center)
American Journal of Respiratory and Critical Care Medicine
September 22, 2011
Cited by 523
Related Papers
An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias
|American Journal of Respiratory and Critical Care Medicine|2013|4.3k
Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline
|American Journal of Respiratory and Critical Care Medicine|2018|4.1k
Nintedanib in Progressive Fibrosing Interstitial Lung Diseases
|New England Journal of Medicine|2019|2.3k